Ontology highlight
ABSTRACT:
SUBMITTER: Morrison RD
PROVIDER: S-EPMC3422546 | biostudies-literature | 2012 Sep
REPOSITORIES: biostudies-literature
Morrison Ryan D RD Blobaum Anna L AL Byers Frank W FW Santomango Tammy S TS Bridges Thomas M TM Stec Donald D Brewer Katrina A KA Sanchez-Ponce Raymundo R Corlew Melany M MM Rush Roger R Felts Andrew S AS Manka Jason J Bates Brittney S BS Venable Daryl F DF Rodriguez Alice L AL Jones Carrie K CK Niswender Colleen M CM Conn P Jeffrey PJ Lindsley Craig W CW Emmitte Kyle A KA Daniels J Scott JS
Drug metabolism and disposition: the biological fate of chemicals 20120618 9
Negative allosteric modulation (NAM) of metabotropic glutamate receptor subtype 5 (mGlu₅) represents a therapeutic strategy for the treatment of childhood developmental disorders, such as fragile X syndrome and autism. VU0409106 emerged as a lead compound within a biaryl ether series, displaying potent and selective inhibition of mGlu₅. Despite its high clearance and short half-life, VU0409106 demonstrated efficacy in rodent models of anxiety after extravascular administration. However, lack of ...[more]